ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 150

Effects of Taping Therapy in the Management of Fibromyalgia: A Randomized Controlled Study

Hae Joo Suh1 and Sang Tae Choi2, 1Seoul National University Hospital, Seoul, Korea, Republic of (South), 2Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia and randomized trials

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia is a medical condition characterized by chronic widespread musculoskeletal pain, accompanied by fatigue, insomnia, cognitive problems, psychiatric symptoms and various somatic symptoms. While a number of pharmacological and nonpharmacological therapies are attempting to treat the patients with fibromyalgia, fibromyalgia is still difficult to manage. Taping therapy has been reported to be effect in relieving pain in a variety of musculoskeletal diseases. However, there were no reports of the patients with fibromyalgia. Therefore, in this study, we aimed to evaluate the effectiveness of taping therapy in fibromyalgia management.

Methods: This is a randomized controlled trial, and total 60 patients with fibromyalgia were enrolled in this study. All patients were met the 2010 American College of Rheumatology (ACR) diagnostic criteria for fibromyalgia. Participants were randomized into the Kinesio taping group (n = 30) and the inelastic paper taping group (n = 30) as control. Kinesio taping therapy or inelastic paper taping was performed twice a week for three weeks in both groups. Three weeks later, Kinesio taping was applied to the control group for additional three week. To assess the effect, the widespread pain index (WPI), severity score (SS) and fibromyalgia impact questionnaire (FIQ) by ACR were used to measure pain, disease severity and dysfunctions in daily life. The Beck depression inventory (BDI) was used to assess depression, and quality of life was assessed by the EQ-5D INDEX and EQ-5D VAS by EurQol group.

Results:

There were no significant differences between the two groups in mean ages, sex ratio and type of medications including anti-depressants and muscle relaxants. The Kinesio taping group showed significant improvement in pain (WPI, 10.50 ± 3.98 vs. 5.70 ± 2.73, p < 0.001), symptom severity (SS, 7.93 ± 2.24 vs. 5.27 ± 1.98, p < 0.001), dysfunction in daily life (FIQ, 65.03 ± 18.75 vs. 43.25 ± 18.87, p < 0.001), depression (BDI, 18.17 ± 8.55 vs. 13.00 ± 6.75, p < 0.001) and QoL (EQ-5D INDEX, 9.10 ± 1.54 vs. 7.67 ± 1.40, p < 0.001; EQ-5D VAS, 38.33 ± 24.65 vs. 56.67 ± 27.93, p < 0.001), respectively. In the control group, however, the significant difference was noted only in pain (WPI, 10.53 ± 3.87 vs. 9.27 ± 3.57, p = 0.014). The changes in the Kinesio taping group before and after treatment showed significant differences compared to the control group; WPI (p < 0.001), SS (p < 0.001), FIQ (p < 0.001), BDI (p = 0.001) , EQ-5D INDEX (p < 0.001), and EQ-5D VAS (p < 0.001), respectively. After changing from inelastic paper taping to Kinesio taping, all parameters have been significant improved (WPI, p <0.001; SS, p <0.001; FIQ, p <0.001; BDI, p <0.001; EQ-5D INDEX, p <0.001; EQ-5D VAS, p <0.001, respectively). There was no serious adverse event to all participants.

Conclusion: This randomized controlled study showed that Kinesio taping therapy is effective in pain, symptom severity, dysfunctions in daily life, depression, and quality of life in patient with fibromyalgia. Taping therapy could be a useful treatment modality in the management of fibromyalgia.


Disclosure: H. J. Suh, None; S. T. Choi, None.

To cite this abstract in AMA style:

Suh HJ, Choi ST. Effects of Taping Therapy in the Management of Fibromyalgia: A Randomized Controlled Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/effects-of-taping-therapy-in-the-management-of-fibromyalgia-a-randomized-controlled-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-taping-therapy-in-the-management-of-fibromyalgia-a-randomized-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology